Jaideep Pandya
Analyst · Jaideep Pandya from On Field Research. Your line is now open
Thank you. Your first question really is around the sales growth, the top line growth of this business. It has sort of remained around about EUR300 million in the last, say, four, five years, despite sort of the ebbs and flows of the market. So do you think -- when you did the due diligence, what is, in your view, the fundamental growth of this business? And like the Clariant acquisition, which was sort of a business within a broader group, which was to a degree less of a focus. Do you think Dyneema also is a case where DSM is a nutrition-based company, and therefore, maybe from a growth point of view, it did not get enough attention and you will be able to unlock the growth potential for this business? That's my first question. The second question is just really around the process itself really. I mean, have you been looking in this area, because, again, obviously, this has been an asset on -- not literally on the market, but it has been rumored that it will come on the market for a few years now. So was this a business which like Clariant, again, you always were focused on acquiring if it ever came to the market or not? And then just finally, could you give us some end market comments around what are you seeing currently in important end markets like autos, electronics, construction, et cetera, based on your sort of recent last month or current month sales? Thanks a lot.